Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: Chloroquine and sulfadoxine-pyrimethamine

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 1 SUPPL., 1996, Pages 87-94

  Schultz, Linda J ^a   Steketee, Richard W ^b   Chitsulo, Lester ^c   Macheso, Alan ^d   Kazembe, Peter ^e   Wirima, Jack J ^f  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c MINISTRY OF HEALTH   (Malawi)

^d Malawi Natl TB Control Programme   (Malawi)

^e KAMUZU CENTRAL HOSPITAL   (Malawi)

^f UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE;

CHEMOPROPHYLAXIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MIXTURE; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MATERNAL DISEASE; ORAL DRUG ADMINISTRATION; PRENATAL CARE;

ANTIMALARIALS; CHLOROQUINE; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALARIA, FALCIPARUM; MALAWI; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME;

EID: 0029684104     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.87     Document Type: Article

References (32)

1. Jeliffe LFP, 1968. Low birth weight and malaria infection of the placenta. Bull World Health Organ 38: 69-78.
2. Kramer MS, 1987. Intrauterine growth determinants and gestational duration determinants. Pediatrics 80: 502-511.
3. McGregor IA, Wilson ME, Billewicz WZ, 1983. Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birth weight, and placental weight. Trans R Soc Trop Med Hyg 77: 232-244.
4. McCormick MC, 1985. Contribution of low birth weight to infant mortality and childhood morbidity. N Eng J Med 312: 82-90.
5. World Health Organization, Division of Family Health, 1980. The incidence of low birth weight: a critical review of available information. World Health Stat Q 33: 197-224.
6. McGregor IA, 1984. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 33: 517-525.
7. Brabin BJ, 1983. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 61: 1005-1016.
8. Cannon DSH, 1968. Malaria and prematurity in the western region of Nigeria. Br Med J 2: 877-878.
9. World Health Organization, 1986. WHO expert committee on malaria. World Health Organ Tech Rep Ser 735: 57-59.
10. McDermott JM, Heymann DL, Wirima JJ, Macheso AP, Wahl RD, Steketee RW. Campbell CC, 1988. Efficacy of chemoprophylaxis in preventing Plasmodium falciparum parasitemia and placental infection in pregnant women in Malawi. Trans R Soc Trop Med Hyg 82: 520-523.
11. Keuter M, van Eijk A, Hoogstrate M, Raasveld N, van de Ree M, Ngwawe WA, Watkins WM, Were JB, Brandling-Bennett AD, 1990. Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega district, Kenya. Br Med J 301: 466-470.
12. Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG, 1996. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg 55 (suppl): 33-41.
13. Schultz LJ, Steketee RW, Chitsulo L, Macheso A, Nyasulu Y, Ettling M, 1994. Malaria and childbearing women in Malawi: knowledge, attitudes and practices. Trop Med Parasitai 45: 65-69.
14. Henderson RH, Sundaresan T, 1982. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ 60: 253-260.
15. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ, 1994. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515-522.
16. Bloland PB, Lackritz EM, Kazmbe PN, Were JBO, Steketee RW, Campbell CC, 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167: 932-937.
17. World Health Organization, 1973. Chemotherapy of malaria and resistance to antimalarials. World Health Organ Tech Rep Ser 529.
18. von Schenck H, Falkensson M, Lundberg B, 1986. Evaluation of "HemoCue," a new device for determining hemoglobin. Clin Chem 32: 526-529.
19. Heymann DL, Steketee RW, Wirima JJ, McFarland DA, Khoromana CO, Campbell CC, 1990. Antenatal chloroquine chemoprophylaxis in Malawi: chloroquine resistance. Trans R Soc Trop Med Hyg 84: 496-498.
20. Bloland PB, Slutsker L, Steketee RW, Wirima JJ, Heymann DL, Breman JG, 1996. Rates and risk factors for mortality during the first two years of life in rural Malawi. Am J Trop Med Hyg 55 (suppl): 82-86.
21. Bjorkman A, Wilcox M, 1986. In vivo and in vitro susceptibility of Plasmodium falciparum to sulfadoxine/pyrimethamine in Liberia, West Africa. Trans R Soc Trop Med Hyg 80: 572-574.
22. Heymann DL, Khoromana CO, Wirima JJ, Campbell CC, 1987. Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi. Trans R Soc Trop Med Hyg 81: 722-724.
23. Kaseje DCO, Sempebwa EKN, Spencer HC, 1987. Malaria ehemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance. Ann Trop Med Parasitol 81: 77-82.
24. Bruce-Chwatt LJ, Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer WH, 1981. Chemotherapy of Malaria. Revised second edition. Geneva: World Health Organization.
25. Silverman WA, Anderson DH, Blanc WA, Crozier DN, 1956. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 18: 614-625.
26. Scholer HJ, Leimer R, Richle R, 1984. Sulphonamides and sulphones. Peters W, Richards WCH, eds. Antimalarial Drugs II. Current Antimalarials and New Drug Developments. New York: Springer-Verlag, 123-206.
27. Baskin CG, Law S, Wenger N, 1980. Sulfadiazine rheumatic fever prophylaxis during pregnancy: does it increase the risk for kernicterus in the newborn? Cardiology 65: 222-225.
28. Greenwood BM, Greenwood AM, Snow RW, Byass P, Bennett S, Hatib-N'Jie AB, 1989. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg 83: 589-594.
29. Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stern R, Campbell CC, 1986. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. Am J Trop Med Hyg 35: 451-458.
30. Bjorkman A, Phillips-Howard PA, 1991. Adverse reactions to sulfa drugs: implications for malaria chemotherapy. Bull World Health Organ 69: 297-304.
31. Phillips-Howard PA, Bjorkman AB, 1990. Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs. Bull World Health Organ 68: 493-504.
32. Schultz LJ, Steketee RW, Chitsulo L, Wirima JJ, 1995. Antimalarials during pregnancy: a cost-effectiveness analysis. Bull World Health Organ 73: 207-214.